Table 2.

Utility weights and prevalence estimates for diabetes mellitus from the ODD/OHS II* and the WHO Global Burden of Disease (GBD) study^†

			WHO Global Burden of Disease (both sexes combined)
Age group (yrs)	HUI3 (DM prevalence %‡)		Treated (prevalence %‡)			Not treated (prevalence unknown)
	Men	Women	Un-complicated DM	Diabetic foot	Blindness	Un-complicated DM	Diabetic foot	Blindness
12–39	0.940 (1.7)	0.932 (2.0)	0.967 (1.8)	0.871 (--)	0.507 (0.0)	0.989	0.863	0.400
40–54	0.915 (7.4)	0.897 (5.6)	0.967 (6.5)	0.871 (--)	0.507 (0.0)	0.989	0.863	0.400
55–69	0.870 (17.2)	0.855 (11.0)	0.967 (13.8)	0.871 (--)	0.507 (0.1)	0.989	0.863	0.400
70+	0.775 (20.9)	0.778 (16.2)	0.967 (17.7)	0.871 (--)	0.507 (0.4)	0.989	0.863	0.400
Total	0.896 (7.0)	0.886 (5.8)	0.967 (6.3)	0.871 (--)	0.507 (0.1)	0.989	0.400	0.400

Abbreviations: DM diabetes mellitus, HUI3 Health Utilities Index Mark III *ODD/OHS II – the 1996/97 Ontario Health Survey linked to the Ontario Diabetes Database; utility weights are HUI3 scores ^†WHO Global Burden of Disease Study [6] – weights are based on expert opinion. ^‡All prevalence estimates are from the OHS II